{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01198171",
            "orgStudyIdInfo": {
                "id": "GOG-8022"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2011-02867",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "CDR0000684547"
                },
                {
                    "id": "GOG-8022"
                },
                {
                    "id": "GOG-8022",
                    "type": "OTHER",
                    "domain": "Gynecologic Oncology Group"
                },
                {
                    "id": "GOG-8022",
                    "type": "OTHER",
                    "domain": "CTEP"
                },
                {
                    "id": "P50CA134254",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/P50CA134254"
                },
                {
                    "id": "R01CA071754",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01CA071754"
                },
                {
                    "id": "R21CA133295",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R21CA133295"
                },
                {
                    "id": "U10CA027469",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U10CA027469"
                },
                {
                    "id": "U10CA037517",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U10CA037517"
                }
            ],
            "organization": {
                "fullName": "GOG Foundation",
                "class": "NETWORK"
            },
            "briefTitle": "Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer",
            "officialTitle": "The Relationship of Racial Genetic Admixture With Endometrial Cancer Outcomes",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "racial-and-genetic-biomarkers-of-response-in-tissue-samples-from-patients-with-endometrial-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2015-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2100-01"
            },
            "primaryCompletionDateStruct": {
                "date": "2100-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2010-09-08",
            "studyFirstSubmitQcDate": "2010-09-08",
            "studyFirstPostDateStruct": {
                "date": "2010-09-09",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2015-05-27",
            "lastUpdatePostDateStruct": {
                "date": "2015-05-29",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Gynecologic Oncology Group",
                "class": "NETWORK"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "descriptionModule": {
            "briefSummary": "This research study is studying racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. DNA analysis of tumor tissue may also help doctors predict how well patients will respond to treatment.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. To identify racial categorization as the proportion of genetic background of African-American or European-American women with endometrioid endometrial cancer (EEC).\n\nII. To evaluate the association of racial genetic admixture with clinicopathologic variables and outcomes.\n\nSECONDARY OBJECTIVES:\n\nI. To compare the concordance between racial genetic admixture and self-designated race categorization.\n\nOUTLINE: This is a multicenter study. Patients are stratified by race (African-American vs European-American) and disease stage (I vs II vs III vs IV).\n\nDNA from archived frozen normal tissue samples is genotyped for the ancestry informative markers. Clinicopathological and demographic characteristics associated with each sample are also collected."
        },
        "conditionsModule": {
            "conditions": [
                "Stage I Uterine Corpus Cancer",
                "Stage II Uterine Corpus Cancer",
                "Stage III Uterine Corpus Cancer",
                "Stage IV Uterine Corpus Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "timePerspective": "RETROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 243,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Basic science (DNA analysis)",
                    "description": "DNA from archived frozen normal tissue samples is genotyped for the ancestry informative markers. Clinicopathological and demographic characteristics associated with each sample are also collected.",
                    "interventionNames": [
                        "Other: Laboratory Biomarker Analysis",
                        "Other: Study of Socioeconomic and Demographic Variables"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Laboratory Biomarker Analysis",
                    "description": "Correlative studies",
                    "armGroupLabels": [
                        "Basic science (DNA analysis)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Study of Socioeconomic and Demographic Variables",
                    "armGroupLabels": [
                        "Basic science (DNA analysis)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Clinicopathologic and demographic characteristics: characteristics: self-reported race, stage, age, race, parity, body-mass index, stage, grade, depth of invasion, lymph-vascular space invasion, and metastasis",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Overall survival",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Progression-free survival",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Proportion of genetic background that is of African-American descent",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Racial genetic admixture score, summarized by race and other clinicopathologic variables",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed endometrial cancer\n\n  * Stage I-IV disease regardless of grade\n  * Underwent surgical staging including hysterectomy, bilateral oophorectomy, washings, and pelvic lymphadenectomy\n* Eligible and evaluated on GOG-0210 clinical trial, a Molecular Staging Study in Endometrial Cancer\n* Available frozen or formalin-fixed and paraffin-embedded normal tissue that is free of tumor cells and yields sufficient high-quality normal DNA for testing\n* Consented their specimens and clinical data to be collected and used in future studies\n* Self-declared African-American or Caucasian race",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patient with endometrial cancer",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Rodney Rocconi",
                    "affiliation": "Gynecologic Oncology Group",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Gynecologic Oncology Group",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19103",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}